Inaktiver Wert

Andere Sprachen Guardion Health Sciences Inc Nasdaq

Aktien

US40145Q2030

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024	21.05.
Guardion Health Sciences Announces	13.05.
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023	29.03.
Guardion Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
North American Morning Briefing : Hopes of March -2-	05.02.
Top Midday Gainers	31.01.
Alphabet Earnings, Upcoming Fed Rate Decision Drive Mixed Premarket Action for US Equity Futures	31.01.
Top Premarket Gainers	31.01.
Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.	31.01.
Doctor's Best, Inc. agreed to acquire Activ Nutritional, LLC. from Guardion Health Sciences, Inc. for $17.2 million.	30.01.
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023	13.11.
Guardion Health Sciences Continues its Strategic Review Process	13.11.
Guardion Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023	14.08.23
Guardion Health Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14.08.23
Guardion Health Sciences, Inc. Announces Executive Changes	31.07.23
US Stock Futures Trend Higher Ahead of Consumer Sentiment Report	30.06.23
Top Premarket Decliners	30.06.23
GUARDION HEALTH SCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	05.06.23
Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer	30.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Guardion Health Sciences Inc Nasdaq

Aktien

US40145Q2030

Andere Sprachen

Filter